查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球醫療過濾市場按材料、工藝技術、設計/工藝、最終用戶、應用和地區分類 - 預測至 2030 年
市場調查報告書
商品編碼
1660050

全球醫療過濾市場按材料、工藝技術、設計/工藝、最終用戶、應用和地區分類 - 預測至 2030 年

Medical Filtration Market by Material (Polyethersulfone; Polyvinylidenefluoride), Applications (Dialysis; Sterile Processing), Process Technology (Ultrafiltration; Microfiltration), Design/Process, End-Users & Region - Global Forecast to 2030
出版日期: | 出版商: MarketsandMarkets | 英文 354 Pages | 訂單完成後即時交付

價格

醫療過濾市場預計將從 2024 年的 62.9 億美元成長到 2030 年的 93.5 億美元，複合年成長率為 6.8%。

對高品質過濾解決方案的迫切需求是該市場的主要驅動力，特別是當醫療保健提供者和研究機構將患者安全與有效產品放在首位時。這就是為什麼先進的過濾技術對於確保去除污染物至關重要。這一趨勢受到嚴格的監管標準以及在醫療保健環境中維持無菌環境日益成長的重要性的影響。此外，實驗室中慢性病的增加也推動了對用於臨床和診斷支援的可靠過濾系統的需求。因此，公司有充足的機會創新和開發專門的過濾產品，以滿足這些不斷變化的需求，加強其市場地位並推動未來成長。

研究範圍
調查年份 2021-2030
基準年 2023
預測期 2024-2030
單位數量 單位數、金額（百萬美元）
部分 按材料、按工藝技術、按設計/工藝、按最終用戶、按應用、按地區
目標區域 亞太地區、北美、歐洲、中東和非洲、南美

PVDF 憑藉其出色的耐化學性、高熱穩定性和良好的機械性能，成為醫療過濾市場中成長速度第二快的材料。這些特性使 PVDF 非常適合要求嚴格的醫療應用，例如無菌過濾和基於膜的設備。 PVDF 與多種滅菌技術相容，包括高壓釜和伽瑪射線照射，這使得 PVDF 非常適合用於醫療過濾。由於它們具有疏水性並且能抵抗刺激性清洗劑，因此它們也越來越受歡迎。醫療保健和生物加工技術的進步推動了對強力、高效過濾介質的需求，從而導致 PVDF 的採用增加。

由於醫院在預防感染和病人安全方面發揮著重要作用，因此佔據了醫療過濾市場的最大市場佔有率。事實上，慢性病、手術和人口老化的激增，再加上住院人數的增加，正在推動對先進過濾系統的需求。醫院嚴重依賴人工呼吸器、靜脈注射系統和手術器械等醫療設備的無菌空氣和水的過濾解決方案。醫院感染控制的成長，加上滿足嚴格監管標準的需要，將導致採用範圍進一步擴大。此外，許多新興經濟體已經開發了醫療保健基礎設施，其中醫院是領先的終端使用產業。

北美佔據醫療過濾市場的最大佔有率，這主要歸功於發達的醫療保健基礎設施、嚴格的監管標準以及高昂的醫療服務支出。此外，該地區許多領先的醫療過濾製造公司的存在也推動了對先進過濾解決方案的需求。隨著慢性病發病率的不斷上升以及人口老化，醫院、實驗室和居家醫療機構對過濾系統的需求也越來越大。正如在北美所看到的那樣，自從新冠肺炎疫情以來，感染控制進一步刺激了先進過濾技術的使用。亞太地區是醫療過濾快速成長的市場，其驅動力來自快速的都市化、不斷擴大的醫療保健基礎設施以及醫療產業不斷增加的投資。其人口數量龐大且老化，加上人們對醫療衛生意識的增強，推動了醫療過濾產品的消費。中國和印度是重要的新興經濟體，兩國政府和醫療旅遊業推動兩國的快速成長。

本報告研究了全球醫療過濾市場，並按材料、製程技術、設計/流程、最終用戶、應用、區域趨勢和公司簡介進行了詳細細分。

目錄

第 1 章 簡介

第2章調查方法

第3章執行摘要

第 4 章重要考察

第5章 市場概況

  • 介紹
  • 市場動態
  • 波特五力分析
  • 主要相關人員和採購標準
  • 宏觀經濟展望
  • 人工智慧/生成式人工智慧的影響
  • 價值鏈分析
  • 生態系分析
  • 案例研究分析
  • 關稅和監管狀況
  • 技術分析
  • 影響客戶業務的趨勢/中斷
  • 貿易分析
  • 2025-2026 年重要會議與活動
  • 定價分析
  • 投資金籌措場景
  • 專利分析

第6章 醫療過濾市場（依材料）

  • 介紹
  • 聚碸和聚醚碸
  • 聚二氟亞乙烯
  • 聚四氟乙烯
  • 聚丙烯
  • 其他

7. 醫療過濾市場（依製程技術）

  • 介紹
  • 超過濾
  • 微濾
  • 奈米過濾
  • 逆滲透
  • 氣體過濾
  • 其他

8. 醫療過濾市場（依設計/工藝）

  • 介紹
  • 系統（RTU單元）
  • 過濾模組（耗材）
  • 其他

9. 醫療過濾市場（依最終用戶分類）

  • 介紹
  • 醫院
  • 診斷中心
  • 研究所
  • 其他

第 10 章 醫療過濾市場（按應用）

  • 介紹
  • 透析
  • 藥物輸送
  • 靜脈輸液和無菌過濾
  • 內視鏡檢查
  • 消毒
  • 生物人工過程
  • 其他

第 11 章 醫療過濾市場（按地區）

  • 介紹
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 其他
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 其他
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 中東和非洲
    • 海灣合作理事會國家
    • 南非
    • 其他
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他

第12章 競爭格局

  • 概述
  • 主要參與企業的策略/優勢
  • 2021-2023 年收益分析
  • 2023 年市場佔有率分析
  • 公司估值與財務指標
  • 產品比較
  • 公司估值矩陣：主要參與企業，2023 年
  • 公司估值矩陣：Start-Ups/中小企業，2023 年
  • 競爭場景

13. 公司簡介-醫療過濾設備供應商

  • 主要參與企業
    • MERCK KGAA
    • 3M（SOLVENTUM）
    • DANAHER
    • SARTORIUS AG
    • ASAHI KASEI CORPORATION
    • BAXTER
    • THERMO FISHER SCIENTIFIC INC.
    • VEOLIA
    • DONALDSON COMPANY, INC.
    • PARKER HANNIFIN CORP
    • ENTEGRIS
    • MANN+HUMMEL
  • 其他公司
    • CORNING INCORPORATED
    • CRITICAL PROCESS FILTRATION, INC.
    • COBETTER
    • GRAVER TECHNOLOGIES
    • ERTELALSOP
    • KASAG SWISS AG
    • FILTROX AG
    • MEMBRANE SOLUTIONS
    • COLE-PARMER INSTRUMENT COMPANY, LLC
    • MEISSNER FILTRATION PRODUCTS, INC.
    • MEDICAL FILTRATION SOLUTIONS LTD.
    • SEFAR AG
    • WALKER FILTRATION
    • SAINT-GOBAIN

14. 公司簡介-自動內視鏡前置處理器供應商

  • 主要參與企業
    • STERIS
    • FORTIVE
    • OLYMPUS CORPORATION
    • ECOLAB
    • GETINGE
    • STEELCOBELIMED（METALL ZUG GROUP）
    • ENDO-TECHNIK W. GRIESAT（CREO）
    • WASSENBURG MEDICAL BV（HOYA CORPORATION）

15. 公司簡介-透析設備供應商

  • 主要參與企業
    • FRESENIUS MEDICAL CARE AG
    • BAXTER
    • DAVITA INC.
    • NIKKISO CO., LTD.
    • B. BRAUN SE
    • NIPRO
    • TORAY MEDICAL CO., LTD.
    • MEDIONICS

第16章 附錄

Product Code: CH 9289

The medical filtration market is projected to reach USD 9.35 billion by 2030 from USD 6.29 billion in 2024, at a CAGR of 6.8%. The urgent demand for quality filtration solutions serves as a major driving force for this market, especially with healthcare providers and research institutions prioritizing patient safety along with effective products. Advanced filtration technologies that ensure the removal of contaminants have therefore become paramount. This trend is majorly influenced by stringent regulatory standards and rising importance of maintaining sterile environments in medical settings. There is also growing demand for reliable filtration systems to support clinical and diagnostics applications, supported by the increase in chronic diseases in laboratories. Hence, the companies have ample opportunities to innovate and develop specialized filtration products catering to such evolving needs and enhancing their market presence and driving future growth.

Scope of the Report
Years Considered for the Study2021-2030
Base Year2023
Forecast Period2024-2030
Units ConsideredUnits; Value (USD Million)
SegmentsMaterial, Process Technology, Design/Process, Application and End-Users
Regions coveredAsia Pacific, North America, Europe, Middle East & Africa, and South America

"Based on material, PVDF is the second fastest growing material in medical filtration market during the forecast period, in terms of value."

PVDF is the second-fastest-growing material in the medical filtration market due to its exceptional chemical resistance, high thermal stability, and excellent mechanical properties. These properties make it very suitable for demanding medical applications like sterile filtration and membrane-based devices. Compatibility with a wide range of sterilization techniques such as autoclaving and gamma radiation makes PVDF highly useful in medical filtration. Its hydrophobic nature and resistance to aggressive cleaning agents also make it increasingly popular. As healthcare and bioprocessing technologies advance, the demand for strong and efficient filtration materials grow increasing the adoption of PVDF .

"Based on end-use industry, hospitals account the largest share in medical filtration market during the forecast period, in terms of value."

The largest market share of the medical filtration market is captured by hospitals due to their role in infection prevention and patient safety. In fact, rising hospital admissions on account of surging chronic diseases, surgical procedures, and the aging population is boosting the demand for advanced filtration systems. Hospitals rely heavily on filtration solutions in terms of sterile air and water for medical devices including ventilators, IV infusion systems, and surgical tools. Growth in infection control in hospitals coupled with the necessity to meet severe regulatory standards leads to further growth in adoption. Moreover, developing healthcare infrastructure in many emerging economies contributes to hospitals' being the top end-use industry.

"Based on region, North America accounts the largest share and Asia pacific is the fastest growing region in medical filtration market, in terms of value."

North America accounts the largest share in medical filtration market majorly because of its developed healthcare infrastructure, strict regulatory standards, and high expenditure on healthcare services. This is further fueled by significant presence of major medical filtration manufacturing companies in the region with high demands for advanced filtration solutions. Increased prevalence of chronic diseases along with an aging population has created a need for more filtration systems within hospitals, laboratories, and in home care. Infection control, as also seen within the North America, has further added to the use of advanced filtration technologies following COVID-19. Asia Pacific is a rapidly growing market for medical filtration, supported by rapid urbanization, expansive healthcare infrastructure growth, and the increasing investments being made in medical industries. Its large and aging population, with improved awareness of healthcare hygiene, encourages the consumption of medical filtration products. China and India are significant emerging economies since the governments and medical tourism drive the country to grow more rapidly.

In the process of determining and verifying the market size for several segments and subsegments identified through secondary research, extensive primary interviews were conducted. A breakdown of the profiles of the primary interviewees are as follows:

  • By Company Type: Tier 1 - 40%, Tier 2 - 30%, and Tier 3 - 30%
  • By Designation: Directors- 35%, Managers - 25%, and Others - 40%
  • By Region: North America - 22%, Europe - 22%, Asia Pacific - 45%, RoW - 11%

The key players in this market are Merck KGaA (Germany), 3M (Solventum) (US), Danaher (US), Sartorius AG (Germany), Veolia (France), Thermo Fisher Scientific Inc (US), Donaldson Company Inc (US), Baxter (US), Parker Hannifin Corp (US), Entegris (US), Asahi Kasei Corporation (Japan), and Mann+Hummel (Germany).

Research Coverage

This report segments the medical filtration market based on material, process technology, design/process, application, end-use industry, and region, and provides estimations for the overall value of the market across various regions. A detailed analysis of key industry players has been conducted to provide insights into their business overviews, products and services, key strategies, new product launches, expansions, and mergers and acquisitions associated with the medical filtration market.

Key benefits of buying this report

This research report focuses on various levels of analysis, including industry analysis (industry trends), market ranking analysis of top players, and company profiles, which together provide an overall view of the competitive landscape, emerging and high-growth segments of the medical filtration market, high-growth regions, and market drivers, restraints, opportunities, and challenges.

The report provides insights on the following pointers:

  • Analysis of key drivers (Growing demand for high quality filtration solutions, Regulatory and quality standards and Growing focus on infection control), restraints (High cost of advanced filtration systems), opportunities (Growing healthcare investment in emerging economies and Advancements in filtration technologies) and challenges (Disposal of filters and Product performance variability).
  • Market Penetration: Comprehensive information on the medical filtration market offered by top players in the global medical filtration market.
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the medical filtration market.
  • Market Development: Comprehensive information about lucrative emerging markets - the report analyzes the markets for medical filtration market across regions.
  • Market Diversification: Exhaustive information about new products, untapped regions, and recent developments in the global medical filtration market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, and manufacturing capabilities of leading players in the medical filtration market

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
    • 1.3.4 CURRENCY CONSIDERED
    • 1.3.5 UNITS CONSIDERED
  • 1.4 STAKEHOLDERS
  • 1.5 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 List of key secondary sources
      • 2.1.1.2 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 List of key primary interview participants
      • 2.1.2.3 Key industry insights
      • 2.1.2.4 Breakdown of interviews with experts
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.2 TOP-DOWN APPROACH
  • 2.3 GROWTH FORECAST
  • 2.4 DATA TRIANGULATION
  • 2.5 FACTOR ANALYSIS
  • 2.6 RESEARCH ASSUMPTIONS
  • 2.7 RESEARCH LIMITATIONS AND RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN MEDICAL FILTRATION MARKET
  • 4.2 MEDICAL FILTRATION MARKET, BY MATERIAL
  • 4.3 MEDICAL FILTRATION MARKET, BY APPLICATION
  • 4.4 MEDICAL FILTRATION MARKET, BY END USER
  • 4.5 MEDICAL FILTRATION MARKET, BY KEY COUNTRY

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing demand for advanced healthcare solutions
      • 5.2.1.2 Rising awareness of infection control
      • 5.2.1.3 Technological advancements
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 High capital investments
      • 5.2.2.2 Stringent regulatory compliance
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing healthcare investments in emerging economies
      • 5.2.3.2 Adoption of single-use technologies
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Speed and yield issues
  • 5.3 PORTER'S FIVE FORCES ANALYSIS
    • 5.3.1 THREAT OF NEW ENTRANTS
    • 5.3.2 THREAT OF SUBSTITUTES
    • 5.3.3 BARGAINING POWER OF SUPPLIERS
    • 5.3.4 BARGAINING POWER OF BUYERS
    • 5.3.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.4 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.4.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 5.4.2 QUALITY
    • 5.4.3 SERVICE
  • 5.5 MACROECONOMIC OUTLOOK
    • 5.5.1 GDP TRENDS AND FORECASTS
  • 5.6 IMPACT OF AI/GEN AI
  • 5.7 VALUE CHAIN ANALYSIS
    • 5.7.1 RAW MATERIAL SUPPLIERS
    • 5.7.2 MANUFACTURERS
    • 5.7.3 DISTRIBUTORS
    • 5.7.4 END USERS
  • 5.8 ECOSYSTEM ANALYSIS
  • 5.9 CASE STUDY ANALYSIS
    • 5.9.1 VALIDATING PEGASUS PRIME VIRUS REMOVAL FILTERS WITH PREFILTERS
    • 5.9.2 ENHANCING DIALYSIS FILTRATION EFFICIENCY - FRESENIUS MEDICAL CARE
    • 5.9.3 BLOOD FILTRATION FOR SEPSIS TREATMENT - CYTOSORBENTS CORPORATION
  • 5.10 TARIFF AND REGULATORY LANDSCAPE
    • 5.10.1 ENVIRONMENTAL REGULATIONS
    • 5.10.2 NORTH AMERICA
    • 5.10.3 ASIA PACIFIC
    • 5.10.4 EUROPE
    • 5.10.5 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.11 TECHNOLOGY ANALYSIS
    • 5.11.1 KEY TECHNOLOGIES
      • 5.11.1.1 Microfiltration
      • 5.11.1.2 Ultrafiltration
      • 5.11.1.3 Nanofiltration
    • 5.11.2 COMPLEMENTARY TECHNOLOGIES
      • 5.11.2.1 Single-use technology
    • 5.11.3 ADJACENT TECHNOLOGIES
      • 5.11.3.1 Chromatography
  • 5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • 5.13 TRADE ANALYSIS
    • 5.13.1 EXPORT SCENARIO (HS CODE 8421)
    • 5.13.2 IMPORT SCENARIO (HS CODE 8421)
  • 5.14 KEY CONFERENCES AND EVENTS, 2025-2026
  • 5.15 PRICING ANALYSIS
    • 5.15.1 AVERAGE SELLING PRICE TREND, BY REGION, 2021-2023
    • 5.15.2 AVERAGE SELLING PRICE TREND, BY APPLICATION, 2021-2023
    • 5.15.3 AVERAGE SELLING PRICE TREND, BY END USER, 2021-2023
  • 5.16 INVESTMENT AND FUNDING SCENARIO
  • 5.17 PATENT ANALYSIS
    • 5.17.1 INTRODUCTION
    • 5.17.2 LEGAL STATUS OF PATENTS
    • 5.17.3 JURISDICTION ANALYSIS

6 MEDICAL FILTRATION MARKET, BY MATERIAL

  • 6.1 INTRODUCTION
  • 6.2 POLYSULFONE & POLYETHERSULFONE
    • 6.2.1 EXCELLENT MECHANICAL STRENGTH, THERMAL STABILITY, AND CHEMICAL RESISTANCE TO BOOST MARKET
  • 6.3 POLYVINYLIDENE FLUORIDE
    • 6.3.1 EXCEPTIONAL CHEMICAL RESISTANCE, THERMAL STABILITY, AND MECHANICAL STRENGTH TO DRIVE MARKET
  • 6.4 POLYTETRAFLUOROETHYLENE
    • 6.4.1 SUPERIOR FILTRATION PERFORMANCE IN CRITICAL MEDICAL APPLICATIONS TO PROPEL DEMAND
  • 6.5 POLYPROPYLENE
    • 6.5.1 EXCELLENT CHEMICAL RESISTANCE, DURABILITY, AND COST-EFFECTIVENESS TO DRIVE DEMAND
  • 6.6 OTHER MATERIALS

7 MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY

  • 7.1 INTRODUCTION
  • 7.2 ULTRAFILTRATION
    • 7.2.1 INCREASING PREVALENCE OF CHRONIC KIDNEY DISEASE AND RISING DEMAND FOR DIALYSIS TREATMENTS TO BOOST MARKET
  • 7.3 MICROFILTRATION
    • 7.3.1 GROWING USAGE IN STERILIZATION, WATER PURIFICATION, AND BIOPHARMACEUTICAL MANUFACTURING TO DRIVE DEMAND
  • 7.4 NANOFILTRATION
    • 7.4.1 LOW ENERGY CONSUMPTION AND HIGH FILTRATION EFFICIENCY TO SUPPORT MARKET GROWTH
  • 7.5 REVERSE OSMOSIS
    • 7.5.1 CRUCIAL ROLE IN ENSURING SAFETY OF WATER IN MEDICAL PROCEDURES TO BOOST MARKET
  • 7.6 GAS FILTRATION
    • 7.6.1 DELIVERY OF HIGH-QUALITY FILTERED AIR TO FUEL GROWTH
  • 7.7 OTHER PROCESS TECHNOLOGIES

8 MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS

  • 8.1 INTRODUCTION
  • 8.2 SYSTEMS (RTU UNITS)
    • 8.2.1 CONVENIENCE, TIME-SAVING BENEFITS, AND ABILITY TO ENSURE CONSISTENT FILTRATION PERFORMANCE TO BOOST MARKET
  • 8.3 FILTRATION MODULES (CONSUMABLES)
    • 8.3.1 RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE DEMAND FOR FILTRATION MODULES IN HEALTHCARE
  • 8.4 OTHER DESIGNS/PROCESSES

9 MEDICAL FILTRATION MARKET, BY END USER

  • 9.1 INTRODUCTION
  • 9.2 HOSPITALS
    • 9.2.1 REQUIREMENT OF HIGH-PURITY WATER FOR WOUND CARE, SURGICAL PROCEDURES, STERILIZATION, AND DIALYSIS TO DRIVE MARKET
  • 9.3 DIAGNOSTIC CENTERS
    • 9.3.1 DEMAND FOR HIGH-PURITY WATER, FLUIDS, AND AIR TO ENSURE RELIABLE DIAGNOSTICS TO DRIVE GROWTH
  • 9.4 RESEARCH INSTITUTES
    • 9.4.1 INCREASE IN BIOLOGICAL STUDIES, AND MEDICAL RESEARCH TO BOOST MARKET
  • 9.5 OTHER END USERS

10 MEDICAL FILTRATION MARKET, BY APPLICATION

  • 10.1 INTRODUCTION
  • 10.2 DIALYSIS
    • 10.2.1 ACCURACY AND OPERATIONAL FILTRATION EFFICIENCY IN BLOOD PURIFICATION TO BOOST GROWTH
  • 10.3 DRUG DELIVERY
    • 10.3.1 PROVISION OF OPTIMAL CONDITIONS THROUGH CONSISTENT FLOW RATES AND MINIMUM PRESSURE DROPS TO FUEL MARKET GROWTH
  • 10.4 IV INFUSION & STERILE FILTRATION
    • 10.4.1 HIGH LEVEL OF PRECISION IN CONTAMINANT REMOVAL WHILE PRESERVING FLUID INTEGRITY TO DRIVE GROWTH
  • 10.5 ENDOSCOPY
    • 10.5.1 ENHANCEMENT OF SAFETY AND PERFORMANCE WITH ADVANCED FILTRATION TO BOOST MARKET
  • 10.6 STERILE PROCESSING
    • 10.6.1 GROWING DEMAND FOR SURGICAL INSTRUMENTS, ENDOSCOPES, AND REUSABLE MEDICAL DEVICES TO PROPEL MARKET
  • 10.7 BIO-ARTIFICIAL PROCESSES
    • 10.7.1 VITAL ROLE OF SOPHISTICATED FILTRATION SYSTEMS IN DEVELOPMENT AND FUNCTIONALITY OF BIO-ARTIFICIAL ORGANS TO BOOST MARKET
  • 10.8 OTHER APPLICATIONS

11 MEDICAL FILTRATION MARKET, BY REGION

  • 11.1 INTRODUCTION
  • 11.2 ASIA PACIFIC
    • 11.2.1 CHINA
      • 11.2.1.1 Strong economic growth and expanding healthcare sector to drive market
    • 11.2.2 JAPAN
      • 11.2.2.1 Growing aging population to propel market
    • 11.2.3 INDIA
      • 11.2.3.1 Increasing investments in healthcare sector to drive market
    • 11.2.4 SOUTH KOREA
      • 11.2.4.1 Rising demand for high-quality medical filtration solutions to drive market
    • 11.2.5 REST OF ASIA PACIFIC
  • 11.3 EUROPE
    • 11.3.1 GERMANY
      • 11.3.1.1 Economic strength, increasing healthcare expenditure, and rapidly aging population to drive market
    • 11.3.2 UK
      • 11.3.2.1 Rising geriatric population to support market growth
    • 11.3.3 FRANCE
      • 11.3.3.1 Aging population and enhancement of healthcare system to propel market
    • 11.3.4 ITALY
      • 11.3.4.1 Growing aging population to increase demand
    • 11.3.5 SPAIN
      • 11.3.5.1 Rising demand for advanced medical solutions to propel market
    • 11.3.6 REST OF EUROPE
  • 11.4 NORTH AMERICA
    • 11.4.1 US
      • 11.4.1.1 Stringent regulatory guidelines and increasing healthcare spending to boost market
    • 11.4.2 CANADA
      • 11.4.2.1 Growing aging population and significant government investments in healthcare infrastructure to drive market growth
    • 11.4.3 MEXICO
      • 11.4.3.1 Government initiatives and growth of healthcare sector to drive market
  • 11.5 MIDDLE EAST & AFRICA
    • 11.5.1 GCC COUNTRIES
      • 11.5.1.1 Saudi Arabia
        • 11.5.1.1.1 Economic growth, increasing government investments, and rising healthcare expenditures to drive market
      • 11.5.1.2 Rest of GCC Countries
    • 11.5.2 SOUTH AFRICA
      • 11.5.2.1 Outbreaks of contagious diseases to drive demand
    • 11.5.3 REST OF MIDDLE EAST & AFRICA
  • 11.6 SOUTH AMERICA
    • 11.6.1 BRAZIL
      • 11.6.1.1 Rising healthcare investments and expanding medical infrastructure to propel growth
    • 11.6.2 ARGENTINA
      • 11.6.2.1 Increasing healthcare expenditure and enhancement of medical infrastructure to drive market
    • 11.6.3 REST OF SOUTH AMERICA

12 COMPETITIVE LANDSCAPE

  • 12.1 OVERVIEW
  • 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 12.3 REVENUE ANALYSIS, 2021-2023
  • 12.4 MARKET SHARE ANALYSIS, 2023
  • 12.5 COMPANY VALUATION AND FINANCIAL METRICS
  • 12.6 PRODUCT COMPARISON
  • 12.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 12.7.1 STARS
    • 12.7.2 EMERGING LEADERS
    • 12.7.3 PERVASIVE PLAYERS
    • 12.7.4 PARTICIPANTS
    • 12.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 12.7.5.1 Region footprint
      • 12.7.5.2 Material footprint
      • 12.7.5.3 Process technology footprint
      • 12.7.5.4 Design/Process footprint
      • 12.7.5.5 Application footprint
      • 12.7.5.6 End user footprint
  • 12.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 12.8.1 PROGRESSIVE COMPANIES
    • 12.8.2 RESPONSIVE COMPANIES
    • 12.8.3 DYNAMIC COMPANIES
    • 12.8.4 STARTING BLOCKS
    • 12.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
      • 12.8.5.1 Detailed list of key startups/SMEs
      • 12.8.5.2 Competitive benchmarking of key startups/SMEs
  • 12.9 COMPETITIVE SCENARIO
    • 12.9.1 PRODUCT LAUNCHES
    • 12.9.2 DEALS
    • 12.9.3 EXPANSIONS
    • 12.9.4 OTHER DEVELOPMENTS

13 COMPANY PROFILES - MEDICAL FILTRATION EQUIPMENT PROVIDERS

  • 13.1 KEY PLAYERS
    • 13.1.1 MERCK KGAA
      • 13.1.1.1 Business overview
      • 13.1.1.2 Products/Solutions/Services offered
      • 13.1.1.3 Recent developments
        • 13.1.1.3.1 Expansions
      • 13.1.1.4 MnM view
        • 13.1.1.4.1 Right to win
        • 13.1.1.4.2 Strategic choices
        • 13.1.1.4.3 Weaknesses and competitive threats
    • 13.1.2 3M (SOLVENTUM)
      • 13.1.2.1 Business overview
      • 13.1.2.2 Products/Solutions/Services offered
      • 13.1.2.3 Recent developments
        • 13.1.2.3.1 Other developments
      • 13.1.2.4 MnM view
        • 13.1.2.4.1 Right to win
        • 13.1.2.4.2 Strategic choices
        • 13.1.2.4.3 Weaknesses and competitive threats
    • 13.1.3 DANAHER
      • 13.1.3.1 Business overview
      • 13.1.3.2 Products/Solutions/Services offered
      • 13.1.3.3 Recent developments
        • 13.1.3.3.1 Deals
        • 13.1.3.3.2 Other developments
      • 13.1.3.4 MnM view
        • 13.1.3.4.1 Right to win
        • 13.1.3.4.2 Strategic choices
        • 13.1.3.4.3 Weaknesses and competitive threats
    • 13.1.4 SARTORIUS AG
      • 13.1.4.1 Business overview
      • 13.1.4.2 Products/Solutions/Services offered
      • 13.1.4.3 Recent developments
        • 13.1.4.3.1 Product launches
      • 13.1.4.4 MnM view
        • 13.1.4.4.1 Right to win
        • 13.1.4.4.2 Strategic choices
        • 13.1.4.4.3 Weaknesses and competitive threats
    • 13.1.5 ASAHI KASEI CORPORATION
      • 13.1.5.1 Business overview
      • 13.1.5.2 Products/Solutions/Services offered
      • 13.1.5.3 MnM view
        • 13.1.5.3.1 Right to win
        • 13.1.5.3.2 Strategic choices
        • 13.1.5.3.3 Weaknesses and competitive threats
    • 13.1.6 BAXTER
      • 13.1.6.1 Business overview
      • 13.1.6.2 Products/Solutions/Services offered
      • 13.1.6.3 Recent developments
        • 13.1.6.3.1 Deals
      • 13.1.6.4 MnM view
        • 13.1.6.4.1 Right to win
        • 13.1.6.4.2 Strategic choices
        • 13.1.6.4.3 Weaknesses and competitive threats
    • 13.1.7 THERMO FISHER SCIENTIFIC INC.
      • 13.1.7.1 Business overview
      • 13.1.7.2 Products/Solutions/Services offered
      • 13.1.7.3 MnM view
    • 13.1.8 VEOLIA
      • 13.1.8.1 Business overview
      • 13.1.8.2 Products/Solutions/Services offered
      • 13.1.8.3 Recent developments
        • 13.1.8.3.1 Product launches
      • 13.1.8.4 MnM view
        • 13.1.8.4.1 Right to win
        • 13.1.8.4.2 Strategic choices
        • 13.1.8.4.3 Weaknesses and competitive threats
    • 13.1.9 DONALDSON COMPANY, INC.
      • 13.1.9.1 Business overview
      • 13.1.9.2 Products/Solutions/Services offered
      • 13.1.9.3 Recent developments
        • 13.1.9.3.1 Expansions
      • 13.1.9.4 MnM view
    • 13.1.10 PARKER HANNIFIN CORP
      • 13.1.10.1 Business overview
      • 13.1.10.2 Products/Solutions/Services offered
      • 13.1.10.3 MnM view
    • 13.1.11 ENTEGRIS
      • 13.1.11.1 Business overview
      • 13.1.11.2 Products/Solutions/Services offered
      • 13.1.11.3 MnM view
    • 13.1.12 MANN+HUMMEL
      • 13.1.12.1 Business overview
      • 13.1.12.2 Products/Solutions/Services offered
      • 13.1.12.3 MnM view
  • 13.2 OTHER PLAYERS
    • 13.2.1 CORNING INCORPORATED
    • 13.2.2 CRITICAL PROCESS FILTRATION, INC.
    • 13.2.3 COBETTER
    • 13.2.4 GRAVER TECHNOLOGIES
    • 13.2.5 ERTELALSOP
    • 13.2.6 KASAG SWISS AG
    • 13.2.7 FILTROX AG
    • 13.2.8 MEMBRANE SOLUTIONS
    • 13.2.9 COLE-PARMER INSTRUMENT COMPANY, LLC
    • 13.2.10 MEISSNER FILTRATION PRODUCTS, INC.
    • 13.2.11 MEDICAL FILTRATION SOLUTIONS LTD.
    • 13.2.12 SEFAR AG
    • 13.2.13 WALKER FILTRATION
    • 13.2.14 SAINT-GOBAIN

14 COMPANY PROFILES - AUTOMATED ENDOSCOPE REPROCESSOR PROVIDERS

  • 14.1 KEY PLAYERS
    • 14.1.1 STERIS
      • 14.1.1.1 Business overview
      • 14.1.1.2 Products/Solutions/Services offered
      • 14.1.1.3 Recent developments
        • 14.1.1.3.1 Deals
      • 14.1.1.4 MnM view
        • 14.1.1.4.1 Right to win
        • 14.1.1.4.2 Strategic choices
        • 14.1.1.4.3 Weaknesses and competitive threats
    • 14.1.2 FORTIVE
      • 14.1.2.1 Business overview
      • 14.1.2.2 Products/Solutions/Services offered
      • 14.1.2.3 Recent developments
        • 14.1.2.3.1 Deals
      • 14.1.2.4 MnM view
        • 14.1.2.4.1 Right to win
        • 14.1.2.4.2 Strategic choices
        • 14.1.2.4.3 Weaknesses and competitive threats
    • 14.1.3 OLYMPUS CORPORATION
      • 14.1.3.1 Business overview
      • 14.1.3.2 Products/Solutions/Services offered
      • 14.1.3.3 Recent developments
        • 14.1.3.3.1 Product launches
      • 14.1.3.4 MnM view
        • 14.1.3.4.1 Right to win
        • 14.1.3.4.2 Strategic choices
        • 14.1.3.4.3 Weaknesses and competitive threats
    • 14.1.4 ECOLAB
      • 14.1.4.1 Business overview
      • 14.1.4.2 Products/Solutions/Services offered
      • 14.1.4.3 Recent developments
        • 14.1.4.3.1 Product launches
      • 14.1.4.4 MnM view
        • 14.1.4.4.1 Right to win
        • 14.1.4.4.2 Strategic choices
        • 14.1.4.4.3 Weaknesses and competitive threats
    • 14.1.5 GETINGE
      • 14.1.5.1 Business overview
      • 14.1.5.2 Products/Solutions/Services offered
      • 14.1.5.3 Recent developments
        • 14.1.5.3.1 Expansions
      • 14.1.5.4 MnM view
        • 14.1.5.4.1 Right to win
        • 14.1.5.4.2 Strategic choices
        • 14.1.5.4.3 Weaknesses and competitive threats
    • 14.1.6 STEELCOBELIMED (METALL ZUG GROUP)
      • 14.1.6.1 Business overview
      • 14.1.6.2 Products/Solutions/Services offered
      • 14.1.6.3 Recent developments
        • 14.1.6.3.1 Deals
      • 14.1.6.4 MnM view
    • 14.1.7 ENDO-TECHNIK W. GRIESAT (CREO)
      • 14.1.7.1 Business overview
      • 14.1.7.2 Products/Solutions/Services offered
      • 14.1.7.3 MnM view
    • 14.1.8 WASSENBURG MEDICAL B.V. (HOYA CORPORATION)
      • 14.1.8.1 Business overview
      • 14.1.8.2 Products/Solutions/Services offered
      • 14.1.8.3 Recent developments
        • 14.1.8.3.1 Deals

15 COMPANY PROFILES - DIALYSIS EQUIPMENT PROVIDERS

  • 15.1 KEY PLAYERS
    • 15.1.1 FRESENIUS MEDICAL CARE AG
      • 15.1.1.1 Business overview
      • 15.1.1.2 Products/Solutions/Services offered
      • 15.1.1.3 Recent developments
        • 15.1.1.3.1 Product launches
        • 15.1.1.3.2 Deals
      • 15.1.1.4 MnM view
        • 15.1.1.4.1 Right to win
        • 15.1.1.4.2 Strategic choices
        • 15.1.1.4.3 Weaknesses and competitive threats
    • 15.1.2 BAXTER
      • 15.1.2.1 Business overview
      • 15.1.2.2 Products/Solutions/Services offered
      • 15.1.2.3 Recent developments
        • 15.1.2.3.1 Deals
      • 15.1.2.4 MnM view
        • 15.1.2.4.1 Right to win
        • 15.1.2.4.2 Strategic choices
        • 15.1.2.4.3 Weaknesses and competitive threats
    • 15.1.3 DAVITA INC.
      • 15.1.3.1 Business overview
      • 15.1.3.2 Products/Solutions/Services offered
      • 15.1.3.3 Recent developments
        • 15.1.3.3.1 Deals
        • 15.1.3.3.2 Expansions
      • 15.1.3.4 MnM view
        • 15.1.3.4.1 Right to win
        • 15.1.3.4.2 Strategic choices
        • 15.1.3.4.3 Weaknesses and competitive threats
    • 15.1.4 NIKKISO CO., LTD.
      • 15.1.4.1 Business overview
      • 15.1.4.2 Products/Solutions/Services offered
      • 15.1.4.3 Recent developments
        • 15.1.4.3.1 Deals
      • 15.1.4.4 MnM view
        • 15.1.4.4.1 Right to win
        • 15.1.4.4.2 Strategic choices
        • 15.1.4.4.3 Weaknesses and competitive threats
    • 15.1.5 B. BRAUN SE
      • 15.1.5.1 Business overview
      • 15.1.5.2 Products/Solutions/Services offered
      • 15.1.5.3 Recent developments
        • 15.1.5.3.1 Product launches
        • 15.1.5.3.2 Expansions
      • 15.1.5.4 MnM view
        • 15.1.5.4.1 Right to win
        • 15.1.5.4.2 Strategic choices
        • 15.1.5.4.3 Weaknesses and competitive threats
    • 15.1.6 NIPRO
      • 15.1.6.1 Business overview
      • 15.1.6.2 Products/Solutions/Services offered
      • 15.1.6.3 Recent developments
        • 15.1.6.3.1 Product launches
    • 15.1.7 TORAY MEDICAL CO., LTD.
      • 15.1.7.1 Business overview
      • 15.1.7.2 Products/Solutions/Services offered
    • 15.1.8 MEDIONICS
      • 15.1.8.1 Business overview
      • 15.1.8.2 Products/Solutions/Services offered

16 APPENDIX

  • 16.1 DISCUSSION GUIDE
  • 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 16.3 CUSTOMIZATION OPTIONS
  • 16.4 RELATED REPORTS
  • 16.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 CAPITAL HEALTHCARE EXPENDITURE, 2020-2023 (USD MILLION)
  • TABLE 2 HEALTHCARE SPENDING, 2023 (USD MILLION)
  • TABLE 3 MEDICAL FILTRATION MARKET: PORTER'S FIVE FORCES ANALYSIS
  • TABLE 4 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
  • TABLE 5 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • TABLE 6 PROJECTED REAL GDP GROWTH (ANNUAL PERCENTAGE CHANGE) OF KEY COUNTRIES, 2019-2023
  • TABLE 7 ANNUAL GDP PERCENTAGE CHANGE AND PROJECTIONS FOR KEY COUNTRIES, 2024-2029
  • TABLE 8 HEALTH EXPENDITURE AS PERCENTAGE OF GDP, 2019-2022
  • TABLE 9 MEDICAL FILTRATION MARKET: ROLE OF PLAYERS IN ECOSYSTEM
  • TABLE 10 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 11 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 12 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 13 EXPORT SCENARIO FOR HS CODE 8421-COMPLIANT PRODUCTS, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 14 IMPORT SCENARIO FOR HS CODE 8421-COMPLIANT PRODUCTS, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • TABLE 15 MEDICAL FILTRATION MARKET: KEY CONFERENCES AND EVENTS, 2025-2026
  • TABLE 16 MEDICAL FILTRATION MARKET, BY MATERIAL, 2021-2023 (UNIT)
  • TABLE 17 MEDICAL FILTRATION MARKET, BY MATERIAL, 2024-2030 (UNIT)
  • TABLE 18 MEDICAL FILTRATION MARKET, BY MATERIAL, 2021-2023 (USD MILLION)
  • TABLE 19 MEDICAL FILTRATION MARKET, BY MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 20 MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021-2023 (UNIT)
  • TABLE 21 MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024-2030 (UNIT)
  • TABLE 22 MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021-2023 (USD MILLION)
  • TABLE 23 MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 24 MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021-2023 (UNIT)
  • TABLE 25 MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024-2030 (UNIT)
  • TABLE 26 MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021-2023 (USD MILLION)
  • TABLE 27 MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024-2030 (USD MILLION)
  • TABLE 28 MEDICAL FILTRATION MARKET, BY END USER, 2021-2023 (UNIT)
  • TABLE 29 MEDICAL FILTRATION MARKET, BY END USER, 2024-2030 (UNIT)
  • TABLE 30 MEDICAL FILTRATION MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 31 MEDICAL FILTRATION MARKET, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 32 MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
  • TABLE 33 MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
  • TABLE 34 MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 35 MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 36 MEDICAL FILTRATION MARKET, BY REGION, 2021-2023 (UNIT)
  • TABLE 37 MEDICAL FILTRATION MARKET, BY REGION, 2024-2030 (UNIT)
  • TABLE 38 MEDICAL FILTRATION MARKET, BY REGION, 2021-2023 (USD MILLION)
  • TABLE 39 MEDICAL FILTRATION MARKET, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 40 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021-2023 (UNIT)
  • TABLE 41 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024-2030 (UNIT)
  • TABLE 42 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 43 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 44 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021-2023 (UNIT)
  • TABLE 45 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024-2030 (UNIT)
  • TABLE 46 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021-2023 (USD MILLION)
  • TABLE 47 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 48 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021-2023 (UNIT)
  • TABLE 49 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024-2030 (UNIT)
  • TABLE 50 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021-2023 (USD MILLION)
  • TABLE 51 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 52 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021-2023 (UNIT)
  • TABLE 53 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024-2030 (UNIT)
  • TABLE 54 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021-2023 (USD MILLION)
  • TABLE 55 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024-2030 (USD MILLION)
  • TABLE 56 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY END USER, 2021-2023 (UNIT)
  • TABLE 57 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY END USER, 2024-2030 (UNIT)
  • TABLE 58 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 59 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 60 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
  • TABLE 61 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
  • TABLE 62 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 63 ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 64 CHINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
  • TABLE 65 CHINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
  • TABLE 66 CHINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 67 CHINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 68 JAPAN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
  • TABLE 69 JAPAN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
  • TABLE 70 JAPAN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 71 JAPAN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 72 INDIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
  • TABLE 73 INDIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
  • TABLE 74 INDIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 75 INDIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 76 SOUTH KOREA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
  • TABLE 77 SOUTH KOREA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
  • TABLE 78 SOUTH KOREA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 79 SOUTH KOREA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 80 REST OF ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
  • TABLE 81 REST OF ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
  • TABLE 82 REST OF ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 83 REST OF ASIA PACIFIC: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 84 EUROPE: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021-2023 (UNIT)
  • TABLE 85 EUROPE: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024-2030 (UNIT)
  • TABLE 86 EUROPE: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 87 EUROPE: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 88 EUROPE: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021-2023 (UNIT)
  • TABLE 89 EUROPE: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024-2030 (UNIT)
  • TABLE 90 EUROPE: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021-2023 (USD MILLION)
  • TABLE 91 EUROPE: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 92 EUROPE: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021-2023 (UNIT)
  • TABLE 93 EUROPE: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024-2030 (UNIT)
  • TABLE 94 EUROPE: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021-2023 (USD MILLION)
  • TABLE 95 EUROPE: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 96 EUROPE: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021-2023 (UNIT)
  • TABLE 97 EUROPE: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024-2030 (UNIT)
  • TABLE 98 EUROPE: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021-2023 (USD MILLION)
  • TABLE 99 EUROPE: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024-2030 (USD MILLION)
  • TABLE 100 EUROPE: MEDICAL FILTRATION MARKET, BY END USER, 2021-2023 (UNIT)
  • TABLE 101 EUROPE: MEDICAL FILTRATION MARKET, BY END USER, 2024-2030 (UNIT)
  • TABLE 102 EUROPE: MEDICAL FILTRATION MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 103 EUROPE: MEDICAL FILTRATION MARKET, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 104 EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
  • TABLE 105 EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
  • TABLE 106 EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 107 EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 108 GERMANY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
  • TABLE 109 GERMANY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
  • TABLE 110 GERMANY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 111 GERMANY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 112 UK: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
  • TABLE 113 UK: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
  • TABLE 114 UK: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 115 UK: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 116 FRANCE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
  • TABLE 117 FRANCE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
  • TABLE 118 FRANCE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 119 FRANCE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 120 ITALY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
  • TABLE 121 ITALY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
  • TABLE 122 ITALY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 123 ITALY: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 124 SPAIN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
  • TABLE 125 SPAIN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
  • TABLE 126 SPAIN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 127 SPAIN: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 128 REST OF EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
  • TABLE 129 REST OF EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
  • TABLE 130 REST OF EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 131 REST OF EUROPE: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 132 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021-2023 (UNIT)
  • TABLE 133 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024-2030 (UNIT)
  • TABLE 134 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 135 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 136 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021-2023 (UNIT)
  • TABLE 137 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024-2030 (UNIT)
  • TABLE 138 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021-2023 (USD MILLION)
  • TABLE 139 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 140 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021-2023 (UNIT)
  • TABLE 141 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024-2030 (UNIT)
  • TABLE 142 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021-2023 (USD MILLION)
  • TABLE 143 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 144 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021-2023 (UNIT)
  • TABLE 145 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024-2030 (UNIT)
  • TABLE 146 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021-2023 (USD MILLION)
  • TABLE 147 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024-2030 (USD MILLION)
  • TABLE 148 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2021-2023 (UNIT)
  • TABLE 149 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2024-2030 (UNIT)
  • TABLE 150 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 151 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 152 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
  • TABLE 153 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
  • TABLE 154 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 155 NORTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 156 US: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
  • TABLE 157 US: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
  • TABLE 158 US: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 159 US: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 160 CANADA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
  • TABLE 161 CANADA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
  • TABLE 162 CANADA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 163 CANADA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 164 MEXICO: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
  • TABLE 165 MEXICO: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
  • TABLE 166 MEXICO: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 167 MEXICO: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 168 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021-2023 (UNIT)
  • TABLE 169 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024-2030 (UNIT)
  • TABLE 170 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 171 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 172 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021-2023 (UNIT)
  • TABLE 173 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024-2030 (UNIT)
  • TABLE 174 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021-2023 (USD MILLION)
  • TABLE 175 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 176 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021-2023 (UNIT)
  • TABLE 177 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024-2030 (UNIT)
  • TABLE 178 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021-2023 (USD MILLION)
  • TABLE 179 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 180 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021-2023 (UNIT)
  • TABLE 181 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024-2030 (UNIT)
  • TABLE 182 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021-2023 (USD MILLION)
  • TABLE 183 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024-2030 (USD MILLION)
  • TABLE 184 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY END USER, 2021-2023 (UNIT)
  • TABLE 185 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY END USER, 2024-2030 (UNIT)
  • TABLE 186 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 187 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 188 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
  • TABLE 189 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
  • TABLE 190 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 191 MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 192 SAUDI ARABIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
  • TABLE 193 SAUDI ARABIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
  • TABLE 194 SAUDI ARABIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 195 SAUDI ARABIA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 196 REST OF GCC COUNTRIES: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
  • TABLE 197 REST OF GCC COUNTRIES: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
  • TABLE 198 REST OF GCC COUNTRIES: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 199 REST OF GCC COUNTRIES: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 200 SOUTH AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
  • TABLE 201 SOUTH AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
  • TABLE 202 SOUTH AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 203 SOUTH AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 204 REST OF MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
  • TABLE 205 REST OF MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
  • TABLE 206 REST OF MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 207 REST OF MIDDLE EAST & AFRICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 208 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021-2023 (UNIT)
  • TABLE 209 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024-2030 (UNIT)
  • TABLE 210 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2021-2023 (USD MILLION)
  • TABLE 211 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 212 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021-2023 (UNIT)
  • TABLE 213 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024-2030 (UNIT)
  • TABLE 214 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2021-2023 (USD MILLION)
  • TABLE 215 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY MATERIAL, 2024-2030 (USD MILLION)
  • TABLE 216 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021-2023 (UNIT)
  • TABLE 217 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024-2030 (UNIT)
  • TABLE 218 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2021-2023 (USD MILLION)
  • TABLE 219 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY PROCESS TECHNOLOGY, 2024-2030 (USD MILLION)
  • TABLE 220 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021-2023 (UNIT)
  • TABLE 221 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024-2030 (UNIT)
  • TABLE 222 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2021-2023 (USD MILLION)
  • TABLE 223 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY DESIGN/PROCESS, 2024-2030 (USD MILLION)
  • TABLE 224 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2021-2023 (UNIT)
  • TABLE 225 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2024-2030 (UNIT)
  • TABLE 226 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2021-2023 (USD MILLION)
  • TABLE 227 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY END USER, 2024-2030 (USD MILLION)
  • TABLE 228 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
  • TABLE 229 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
  • TABLE 230 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 231 SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 232 BRAZIL: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
  • TABLE 233 BRAZIL: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
  • TABLE 234 BRAZIL: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 235 BRAZIL: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 236 ARGENTINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
  • TABLE 237 ARGENTINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
  • TABLE 238 ARGENTINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 239 ARGENTINA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 240 REST OF SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (UNIT)
  • TABLE 241 REST OF SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (UNIT)
  • TABLE 242 REST OF SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2021-2023 (USD MILLION)
  • TABLE 243 REST OF SOUTH AMERICA: MEDICAL FILTRATION MARKET, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 244 MEDICAL FILTRATION MARKET: DEGREE OF COMPETITION
  • TABLE 245 MEDICAL FILTRATION MARKET: REGION FOOTPRINT
  • TABLE 246 MEDICAL FILTRATION MARKET: MATERIAL FOOTPRINT
  • TABLE 247 MEDICAL FILTRATION MARKET: PROCESS TECHNOLOGY FOOTPRINT
  • TABLE 248 MEDICAL FILTRATION MARKET: DESIGN/PROCESS FOOTPRINT
  • TABLE 249 MEDICAL FILTRATION MARKET: APPLICATION FOOTPRINT
  • TABLE 250 MEDICAL FILTRATION MARKET: END USER FOOTPRINT
  • TABLE 251 MEDICAL FILTRATION MARKET: KEY STARTUPS/SMES
  • TABLE 252 MEDICAL FILTRATION MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES
  • TABLE 253 MEDICAL FILTRATION MARKET: PRODUCT LAUNCHES, JANUARY 2019-JANUARY 2025
  • TABLE 254 MEDICAL FILTRATION MARKET: DEALS, JANUARY 2019-JANUARY 2025
  • TABLE 255 MEDICAL FILTRATION MARKET: EXPANSIONS, JANUARY 2019-JANUARY 2025
  • TABLE 256 MEDICAL FILTRATION MARKET: OTHER DEVELOPMENTS, JANUARY 2019-JANUARY 2025
  • TABLE 257 MERCK KGAA: COMPANY OVERVIEW
  • TABLE 258 MERCK KGAA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 259 MERCK KGAA: EXPANSIONS, JANUARY 2019-JANUARY 2025
  • TABLE 260 3M (SOLVENTUM): COMPANY OVERVIEW
  • TABLE 261 3M (SOLVENTUM): PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 262 3M (SOLVENTUM): OTHER DEVELOPMENTS, JANUARY 2019-JANUARY 2025
  • TABLE 263 DANAHER: COMPANY OVERVIEW
  • TABLE 264 DANAHER: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 265 DANAHER: DEALS, JANUARY 2019-JANUARY 2025
  • TABLE 266 DANAHER: OTHERS, JANUARY 2019-JANUARY 2025
  • TABLE 267 SARTORIUS AG: COMPANY OVERVIEW
  • TABLE 268 SARTORIUS AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 269 SARTORIUS AG: PRODUCT LAUNCHES, JANUARY 2019-JANUARY 2025
  • TABLE 270 ASAHI KASEI CORPORATION: COMPANY OVERVIEW
  • TABLE 271 ASAHI KASEI CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 272 BAXTER: COMPANY OVERVIEW
  • TABLE 273 BAXTER: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 274 BAXTER: DEALS, JANUARY 2019-JANUARY 2025
  • TABLE 275 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
  • TABLE 276 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 277 VEOLIA: COMPANY OVERVIEW
  • TABLE 278 VEOLIA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 279 VEOLIA: PRODUCT LAUNCHES, JANUARY 2019-JANUARY 2025
  • TABLE 280 DONALDSON COMPANY, INC.: COMPANY OVERVIEW
  • TABLE 281 DONALDSON COMPANY, INC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 282 DONALDSON COMPANY, INC.: EXPANSIONS, JANUARY 2019-JANUARY 2025
  • TABLE 283 PARKER HANNIFIN CORP: COMPANY OVERVIEW
  • TABLE 284 PARKER HANNIFIN CORP: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 285 ENTEGRIS: COMPANY OVERVIEW
  • TABLE 286 ENTEGRIS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 287 MANN+HUMMEL: COMPANY OVERVIEW
  • TABLE 288 MANN+HUMMEL: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 289 CORNING INCORPORATED: COMPANY OVERVIEW
  • TABLE 290 CRITICAL PROCESS FILTRATION, INC.: COMPANY OVERVIEW
  • TABLE 291 COBETTER: COMPANY OVERVIEW
  • TABLE 292 GRAVER TECHNOLOGIES: COMPANY OVERVIEW
  • TABLE 293 ERTELALSOP: COMPANY OVERVIEW
  • TABLE 294 KASAG SWISS AG: COMPANY OVERVIEW
  • TABLE 295 FILTROX AG: COMPANY OVERVIEW
  • TABLE 296 MEMBRANE SOLUTIONS: COMPANY OVERVIEW
  • TABLE 297 COLE-PARMER INSTRUMENT COMPANY, LLC: COMPANY OVERVIEW
  • TABLE 298 MEISSNER FILTRATION PRODUCTS, INC.: COMPANY OVERVIEW
  • TABLE 299 MEDICAL FILTRATION SOLUTIONS LTD.: COMPANY OVERVIEW
  • TABLE 300 SEFAR AG: COMPANY OVERVIEW
  • TABLE 301 WALKER FILTRATION: COMPANY OVERVIEW
  • TABLE 302 SAINT-GOBAIN: COMPANY OVERVIEW
  • TABLE 303 STERIS: COMPANY OVERVIEW
  • TABLE 304 STERIS: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 305 STERIS: DEALS, JANUARY 2019-JANUARY 2025
  • TABLE 306 FORTIVE: COMPANY OVERVIEW
  • TABLE 307 FORTIVE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 308 FORTIVE: DEALS, JANUARY 2019-JANUARY 2025
  • TABLE 309 OLYMPUS CORPORATION: COMPANY OVERVIEW
  • TABLE 310 OLYMPUS CORPORATION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 311 OLYMPUS CORPORATION: PRODUCT LAUNCHES, JANUARY 2019-JANUARY 2025
  • TABLE 312 ECOLAB: COMPANY OVERVIEW
  • TABLE 313 ECOLAB: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 314 ECOLAB: PRODUCT LAUNCHES, JANUARY 2019-JANUARY 2025
  • TABLE 315 GETINGE: COMPANY OVERVIEW
  • TABLE 316 GETINGE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 317 GETINGE: EXPANSIONS, JANUARY 2019-JANUARY 2025
  • TABLE 318 STEELCOBELIMED (METALL ZUG GROUP): COMPANY OVERVIEW
  • TABLE 319 STEELCOBELIMED (METALL ZUG GROUP): PRODUCTS/SOLUTIONS/ SERVICES OFFERED
  • TABLE 320 STEELCOBELIMED (METALL ZUG GROUP): DEALS, JANUARY 2019-JANUARY 2025
  • TABLE 321 ENDO-TECHNIK W. GRIESAT (CREO): COMPANY OVERVIEW
  • TABLE 322 ENDO-TECHNIK W. GRIESAT (CREO): PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 323 WASSENBURG MEDICAL B.V. (HOYA CORPORATION): COMPANY OVERVIEW
  • TABLE 324 WASSENBURG MEDICAL B.V. (HOYA CORPORATION): PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 325 WASSENBURG MEDICAL B.V. (HOYA CORPORATION): DEALS, JANUARY 2019-JANUARY 2025
  • TABLE 326 FRESENIUS MEDICAL CARE AG: COMPANY OVERVIEW
  • TABLE 327 FRESENIUS MEDICAL CARE AG: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 328 FRESENIUS MEDICAL CARE AG: PRODUCT LAUNCHES, JANUARY 2019-JANUARY 2025
  • TABLE 329 FRESENIUS MEDICAL CARE AG: DEALS, JANUARY 2019-JANUARY 2025
  • TABLE 330 BAXTER: COMPANY OVERVIEW
  • TABLE 331 BAXTER: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 332 BAXTER: DEALS, JANUARY 2019-JANUARY 2025
  • TABLE 333 DAVITA INC.: COMPANY OVERVIEW
  • TABLE 334 DAVITA INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 335 DAVITA INC.: DEALS, JANUARY 2019-JANUARY 2025
  • TABLE 336 DAVITA INC.: EXPANSIONS, JANUARY 2019-JANUARY 2025
  • TABLE 337 NIKKISO CO., LTD.: COMPANY OVERVIEW
  • TABLE 338 NIKKISO CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 339 NIKKISO CO., LTD.: DEALS, JANUARY 2019-JANUARY 2025
  • TABLE 340 B. BRAUN SE: COMPANY OVERVIEW
  • TABLE 341 B. BRAUN SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 342 B. BRAUN SE: PRODUCT LAUNCHES, JANUARY 2019-JANUARY 2025
  • TABLE 343 B. BRAUN SE: EXPANSIONS, JANUARY 2019-JANUARY 2025
  • TABLE 344 NIPRO: COMPANY OVERVIEW
  • TABLE 345 NIPRO: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 346 NIPRO: PRODUCT LAUNCHES, JANUARY 2019-JANUARY 2025
  • TABLE 347 TORAY MEDICAL CO., LTD.: COMPANY OVERVIEW
  • TABLE 348 TORAY MEDICAL CO., LTD.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 349 MEDIONICS: COMPANY OVERVIEW
  • TABLE 350 MEDIONICS: PRODUCTS/SOLUTIONS/SERVICES OFFERED

List of Figures

  • FIGURE 1 MEDICAL FILTRATION MARKET AND REGIONAL SCOPE
  • FIGURE 2 MEDICAL FILTRATION MARKET: RESEARCH DESIGN
  • FIGURE 3 MEDICAL FILTRATION MARKET: BOTTOM-UP APPROACH
  • FIGURE 4 MEDICAL FILTRATION MARKET: TOP-DOWN APPROACH
  • FIGURE 5 MARKET SIZE ESTIMATION: MEDICAL FILTRATION MARKET (TOP-DOWN APPROACH)
  • FIGURE 6 DEMAND-SIDE FORECAST PROJECTIONS: DRIVERS
  • FIGURE 7 MEDICAL FILTRATION MARKET: DATA TRIANGULATION
  • FIGURE 8 POLYSULFONE & POLYETHERSULFONE SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 9 DIALYSIS APPLICATION TO LEAD MARKET DURING FORECAST PERIOD
  • FIGURE 10 HOSPITALS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 11 ASIA PACIFIC TO BE FASTEST-GROWING MARKET DURING FORECAST PERIOD
  • FIGURE 12 GROWING FOCUS ON INFECTION CONTROL IN HEALTHCARE SECTOR TO DRIVE MARKET
  • FIGURE 13 POLYSULFONE & POLYETHERSULFONE SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 14 IV INFUSION & STERILE FILTRATION SEGMENT TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 15 HOSPITALS TO BE LARGEST END USER SEGMENT DURING FORECAST PERIOD
  • FIGURE 16 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 17 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES IN MEDICAL FILTRATION MARKET
  • FIGURE 18 MEDICAL FILTRATION MARKET: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE END USERS
  • FIGURE 20 KEY BUYING CRITERIA FOR TOP THREE END USERS
  • FIGURE 21 MEDICAL FILTRATION MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 22 MEDICAL FILTRATION MARKET: ECOSYSTEM
  • FIGURE 23 MEDICAL FILTRATION MARKET: TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS
  • FIGURE 24 EXPORT DATA FOR HS CODE 8421-COMPLIANT PRODUCTS, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • FIGURE 25 IMPORT DATA FOR HS CODE 8421-COMPLIANT PRODUCTS, BY COUNTRY, 2019-2023 (USD THOUSAND)
  • FIGURE 26 AVERAGE SELLING PRICE TREND, BY REGION, 2021-2023 (USD/UNIT)
  • FIGURE 27 AVERAGE SELLING PRICE TREND, BY APPLICATION, 2021-2023 (USD/UNIT)
  • FIGURE 28 AVERAGE SELLING PRICE TREND, BY END USER, 2021-2023 (USD/UNIT)
  • FIGURE 29 INVESTMENT AND FUNDING SCENARIO, 2020-2024 (USD MILLION)
  • FIGURE 30 PATENTS APPLIED AND GRANTED, 2014-2024
  • FIGURE 31 LEGAL STATUS OF PATENTS, 2014-2024
  • FIGURE 32 TOP JURISDICTIONS
  • FIGURE 33 POLYETHERSULFONE & POLYETHERSULFONE SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 34 MICROFILTRATION SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 35 FILTRATION MODULES (CONSUMABLES) SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 36 HOSPITALS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 37 DIALYSIS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD
  • FIGURE 38 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
  • FIGURE 39 ASIA PACIFIC: MEDICAL FILTRATION MARKET SNAPSHOT
  • FIGURE 40 EUROPE: MEDICAL FILTRATION MARKET SNAPSHOT
  • FIGURE 41 NORTH AMERICA: MEDICAL FILTRATION MARKET SNAPSHOT
  • FIGURE 42 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN MEDICAL FILTRATION MARKET BETWEEN 2019 AND 2024
  • FIGURE 43 REVENUE ANALYSIS OF TOP FIVE PLAYERS IN MEDICAL FILTRATION MARKET, 2021-2023
  • FIGURE 44 MARKET SHARE OF KEY COMPANIES IN MEDICAL FILTRATION MARKET, 2023
  • FIGURE 45 VALUATION OF LEADING COMPANIES IN MEDICAL FILTRATION MARKET, 2023
  • FIGURE 46 FINANCIAL METRICS OF LEADING COMPANIES IN MEDICAL FILTRATION MARKET, 2023
  • FIGURE 47 MEDICAL FILTRATION MARKET: PRODUCT COMPARISON ANALYSIS
  • FIGURE 48 COMPANY EVALUATION MATRIX, KEY PLAYERS, 2023
  • FIGURE 49 MEDICAL FILTRATION MARKET: OVERALL COMPANY FOOTPRINT
  • FIGURE 50 COMPANY EVALUATION MATRIX, STARTUPS/SMES, 2023
  • FIGURE 51 MERCK KGAA: COMPANY SNAPSHOT
  • FIGURE 52 3M (SOLVENTUM): COMPANY SNAPSHOT
  • FIGURE 53 DANAHER: COMPANY SNAPSHOT
  • FIGURE 54 SARTORIUS AG: COMPANY SNAPSHOT
  • FIGURE 55 ASAHI KASEI CORPORATION: COMPANY SNAPSHOT
  • FIGURE 56 BAXTER: COMPANY SNAPSHOT
  • FIGURE 57 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT
  • FIGURE 58 VEOLIA: COMPANY SNAPSHOT
  • FIGURE 59 DONALDSON COMPANY, INC.: COMPANY SNAPSHOT
  • FIGURE 60 PARKER HANNIFIN CORP: COMPANY SNAPSHOT
  • FIGURE 61 ENTEGRIS: COMPANY SNAPSHOT
  • FIGURE 62 MANN+HUMMEL: COMPANY SNAPSHOT
  • FIGURE 63 STERIS: COMPANY SNAPSHOT
  • FIGURE 64 FORTIVE: COMPANY SNAPSHOT
  • FIGURE 65 OLYMPUS CORPORATION: COMPANY SNAPSHOT
  • FIGURE 66 ECOLAB: COMPANY SNAPSHOT
  • FIGURE 67 GETINGE: COMPANY SNAPSHOT
  • FIGURE 68 STEELCOBELIMED (METALL ZUG GROUP): COMPANY SNAPSHOT
  • FIGURE 69 FRESENIUS MEDICAL CARE AG: COMPANY SNAPSHOT
  • FIGURE 70 BAXTER: COMPANY SNAPSHOT
  • FIGURE 71 DAVITA INC.: COMPANY SNAPSHOT
  • FIGURE 72 NIKKISO CO., LTD.: COMPANY SNAPSHOT
  • FIGURE 73 B. BRAUN SE: COMPANY SNAPSHOT
  • FIGURE 74 NIPRO: COMPANY SNAPSHOT
  • FIGURE 75 TORAY MEDICAL CO., LTD.: COMPANY SNAPSHOT